| Accession Number | 0002010019-26-000028 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Sep 1, 2026 | Sale | 1,000 | $319.76 | $319,758.20 | 128,019 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Sep 1, 2026 | Sale | 1,400 | $320.92 | $449,291.50 | 126,619 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Sep 1, 2026 | Sale | 600 | $321.91 | $193,144.02 | 126,019 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Sep 2, 2026 | Sale | 15,160 | $326.89 | $4,955,713.04 | 110,859 | Direct | โ | View Details |